-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Grants Breakthrough Device Designation to Pharaoh Neuro's Neurapheresis™ CSF Management System

Barchart·10/28/2026 08:33:00
Listen to the news

Designation recognizes the potential of Neurapheresis to offer advantages over existing treatment options following aneurysmal subarachnoid hemorrhage (aSAH)

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.